You are here

  • Home
  • Archive
  • Volume 60, Issue 1
  • Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)

Article info

Article menu
Download PDFPDF
Cancer genetics
Original research
Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)

Authors

  • Alexander J Thompson Manchester Centre for Health Economics, Division of Population Health, Health Services Research and Primary Care, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Yousef M Alwan Department of Clinical Radiology, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Vijay A C Ramani Department of Urology, The Christie NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • D Gareth Evans Division of Evolution and Genomic Medicine, The University of Manchester, Manchester, UK Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Eamonn R Maher Department of Medical Genetics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK PubMed articlesGoogle scholar articles
  • Emma R Woodward Division of Evolution and Genomic Medicine, The University of Manchester, Manchester, UK Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Emma R Woodward, Manchester University NHS Foundation Trust, Manchester M13 9PL, UK; Emma.Woodward{at}mft.nhs.uk
View Full Text

Citation

Thompson AJ, Alwan YM, Ramani VAC, et al
Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)
Journal of Medical Genetics 2023;60:41-47.

Publication history

  • Received September 22, 2021
  • Accepted January 11, 2022
  • First published February 4, 2022.
Online issue publication 
December 23, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.